High-Risk Pregnancies Require More Emotional Support
Women with medically high-risk pregnancies feel they need to suppress their feelings of stress to protect the health of their fetus.
Related Articles
FDA Approves Deuruxolitinib for Treatment of Severe Alopecia Areata
Adults with severe alopecia were shown to have statistically significant efficacy across 2 phase 3 clinical studies highlighted in this announcement.
New Topline Data Released on Epinephrine Sublingual Film for Severe Allergies
These new data were announced by Aquestive Therapeutics and if approved, Anaphylm Sublingual Film could be the first orally-delivered, non-invasive severe allergy treatment.
Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS
Bludorn joins Lungcast to review the increasing effects and signs of heat-related illness amid record-high temperatures.
Sozinibercept Combination Therapy Exhibits Durability for nAMD, DME
Intravitreal dosing of sozinibercept up to 2 mg in combination with ranibizumab or aflibercept was well tolerated and supported ≥Q8W dosing intervals.
FDA Approves Label Expansion for Maralixibat (Livmarli) in PFIC
The expanded label includes use in patients with PFIC 12 months of age and older as well as a higher concentration formulation.
Study Links Air Pollution Exposure During Pregnancy to Reduced Lung Function in Childhood
These data highlighted the association of moderate air pollution exposure during pregnancy, infancy, and early childhood on pulmonary function at school age.
Improving Schizophrenia Management: A Patient’s Call to Care Providers
Schizophrenia experts discuss the stigma and misconceptions surrounding schizophrenia as well as current treatment options.
Periodic Text Messages Can Improve Daily Activity During Cardiac Rehab
Personalized text messages can boost physical activity in cardiac rehab patients, especially in early stages, but effectiveness varies by time and device, study finds.
New Data Highlights Nemolizumab with TCS Versus Calcineurin Inhibitors for Eczema
These new phase 3 findings from ARCADIA 1 and 2 highlight the effects of nemolizumab in combination with either topical corticosteroids or topical calcineurin inhibitors.
Lebrikizumab Shown to Have Comparable Efficacy to Dupilumab for Eczema
This meta-analysis was conducted to compare the efficacy and safety of lebrikizumab to other systemic treatments for patients with atopic dermatitis.